Quris AI
quris.ai
Actively hiring
Artificial Intelligence
E-learning
Machine Learning
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$28M
1 round on record
Latest round
$28M
Venture round · Jan 2022 · 4 yr ago
Backers
1
Vox Capital
The money's age
Long since its last round
56 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2019
Founded
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2022 | $28M | — | www.israelhayom.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Vox Capital Similar startupsby what they do, their industry and backers
ONCOSOFT · CLOUD PLATFORM. Easy access and management of data. All data can be stored in the cloud safely. · DEEP LEARNING.
Mbr targeting. machine learning for user centric optimization.
Jether Energy Research utilizes big data and machine learning to predict power generation and demand, improving grid stability and risk…
Lantern uses cutting-edge machine learning to guide what, when, and how distributors buy.
By using reality capture, game engine tech and machine learning Twinverse provides 3D solutions for operations and maintenance.
We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate…
News
Merck KGaA, Quris-AI Extend Current Collaboration PharmExec
Deal comes amid first successful partnership.
Read more
Report
Report
Quris-AI Acquires Nortis to Enhance Bio-AI Platform - M&A
Quris-AI acquires Nortis to enhance its Bio-AI platform with Kidney-on-Chip technology, improving drug safety prediction and accelerating...
Read more
Report
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
Companies Extend Collaboration After Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety PlatformBOSTON and TEL AVIV, Israel, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Quris-AI, an artificial intelligence (AI) innovator disrupting the pharmaceut
Read more
Report
Quris-AI: How This Company Is Redefining Drug Development Using AI/ML
Quris-AI is an artificial intelligence company that is disrupting drug development and its machine-learning bio-platform better predicts which drug candidates will safely work in humans, avoiding major costs of failed clinical trials. To learn more about
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Tel Aviv
Israel
Regional office
114 Yigal Alon Street, Tel Aviv-Yafo, IL
Financials
Total raised
$28M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2022 | $28M | Details |